{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:36:26Z","timestamp":1771684586075,"version":"3.50.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11033-020-05536-x","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:03:05Z","timestamp":1590796985000},"page":"4767-4778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis"],"prefix":"10.1007","volume":"47","author":[{"given":"Mohsen","family":"Maleknia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Shahrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Ghanavat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Vosoughi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmaldin","family":"Saki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"key":"5536_CR1","first-page":"110","volume":"272","author":"R Ma\u0142ecki","year":"2016","unstructured":"Ma\u0142ecki R, Gacka M, Kuliszkiewicz-Janus M, Jakobsche-Policht U, Kwiatkowski J, Adamiec R et al (2016) Altered plasma fibrin clot properties in essential thrombocythemia. Platelets 272:110\u2013116","journal-title":"Platelets"},{"issue":"6","key":"5536_CR2","first-page":"397","volume":"16","author":"\u00c9 P\u00f3sfai","year":"2016","unstructured":"P\u00f3sfai \u00c9, Marton I, Borb\u00e9nyi Z, Nemes A (2016) Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera. Anatol J Cardiol 16(6):397\u2013402","journal-title":"Anatol J Cardiol"},{"key":"5536_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-019-02005-6","author":"H Alipanahzadeh","year":"2019","unstructured":"Alipanahzadeh H, Ghulamreza R, Shokouhian M, Bagheri M, Maleknia M (2019) Deep vein thrombosis: a less noticed complication in hematologic malignancies and immunologic disorders. J Thromb Thrombolysis. https:\/\/doi.org\/10.1007\/s11239-019-02005-6","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"5536_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11739-009-0319-3","volume":"5","author":"AM Vannucchi","year":"2010","unstructured":"Vannucchi AM (2010) Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia. Intern Emerg Med 5(3):177\u2013184","journal-title":"Intern Emerg Med"},{"issue":"6","key":"5536_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/ejh.12759","volume":"97","author":"V Buxhofer-Ausch","year":"2016","unstructured":"Buxhofer-Ausch V, Steurer M, Sormann S, Schloegl E, Schimetta W, Gisslinger B et al (2016) Influence of platelet and white blood cell counts on major thrombosis\u2014analysis from a patient registry in essential thrombocythemia. Eur J Haematol 97(6):511\u2013516","journal-title":"Eur J Haematol"},{"issue":"1","key":"5536_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ajh.23590","volume":"89","author":"M Marchetti","year":"2014","unstructured":"Marchetti M, Tartari CJ, Russo L, Panova-Noeva M, Leuzzi A, Rambaldi A et al (2014) Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia. Am J Hematol 89(1):68\u201373","journal-title":"Am J Hematol"},{"issue":"5","key":"5536_CR7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.20452\/pamw.3429","volume":"126","author":"K Stankowska","year":"2016","unstructured":"Stankowska K, Gadomska G, Boinska J, Michalska M, Bartoszewska-Kubiak A, Ro\u015b\u0107 D (2016) Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia. Pol Arch Med Wewn 126(5):340\u2013346","journal-title":"Pol Arch Med Wewn"},{"issue":"2","key":"5536_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21593","volume":"85","author":"V De Stefano","year":"2010","unstructured":"De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E et al (2010) Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. Am J Hematol 85(2):97\u2013100","journal-title":"Am J Hematol"},{"issue":"1","key":"5536_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-017-0425-z","volume":"10","author":"F Lussana","year":"2017","unstructured":"Lussana F, Carobbio A, Salmoiraghi S, Guglielmelli P, Vannucchi AM, Bottazzi B et al (2017) Driver mutations (JAK2V617F, MPLW515L\/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera. J Hematol Oncol 10(1):54","journal-title":"J Hematol Oncol"},{"issue":"3","key":"5536_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.thromres.2010.06.025","volume":"126","author":"J Duchemin","year":"2010","unstructured":"Duchemin J, Ugo V, Ianotto JC, Lecucq L, Mercier B, Abgrall JF (2010) Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms. Thromb Res 126(3):238\u2013242","journal-title":"Thromb Res"},{"issue":"2","key":"5536_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00277-013-1838-6","volume":"93","author":"AP Trifa","year":"2014","unstructured":"Trifa AP, Cucuianu A, Popp RA, Coad\u0103 CA, Costache RM, Militaru MS et al (2014) The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia. Ann Hematol 93(2):203\u2013209","journal-title":"Ann Hematol"},{"issue":"1","key":"5536_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3324\/haematol.10634","volume":"92","author":"G Finazzi","year":"2007","unstructured":"Finazzi G, Rambaldi A, Guerini V, Carobbo A, Barbui T (2007) Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status. Haematologica 92(1):135\u2013136","journal-title":"Haematologica"},{"issue":"5","key":"5536_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.thromres.2015.02.023","volume":"135","author":"Y Lim","year":"2015","unstructured":"Lim Y, Lee JO, Kim SH, Kim JW, Kim YJ, Lee KW et al (2015) Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden. Thromb Res 135(5):846\u2013851","journal-title":"Thromb Res"},{"issue":"4","key":"5536_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminhematol.2005.05.023","volume":"42","author":"A Falanga","year":"2005","unstructured":"Falanga A, Marchetti M, Barbui T, Smith CW (2005) Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils. Semin Hematol 42(4):239\u2013247","journal-title":"Semin Hematol"},{"issue":"4","key":"5536_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2174\/1570161043385420","volume":"2","author":"TW Stief","year":"2004","unstructured":"Stief TW (2004) Regulation of hemostasis by singlet-oxygen (1DeltaO2*). Curr Vasc Pharmacol 2(4):357\u2013362","journal-title":"Curr Vasc Pharmacol"},{"issue":"16\u201317","key":"5536_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.clinbiochem.2012.07.100","volume":"45","author":"C Musolino","year":"2012","unstructured":"Musolino C, Allegra A, Saija A, Alonci A, Russo S, Spatari G et al (2012) Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia. Clin Biochem 45(16\u201317):1439\u20131443","journal-title":"Clin Biochem"},{"issue":"10","key":"5536_CR17","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1074\/jbc.275.10.6819","volume":"275","author":"GR Sambrano","year":"2000","unstructured":"Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR (2000) Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275(10):6819\u20136823","journal-title":"J Biol Chem"},{"issue":"2","key":"5536_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1160\/TH17-05-0348","volume":"118","author":"M Lindquist Liljeqvist","year":"2018","unstructured":"Lindquist Liljeqvist M, Silveira A, Hultgren R, Frebelius S, Lengquist M, Engstr\u00f6m J et al (2018) Neutrophil elastase-derived fibrin degradation products indicate presence of abdominal aortic aneurysms and correlate with intraluminal thrombus volume. Thromb Haemost 118(2):329\u2013339","journal-title":"Thromb Haemost"},{"issue":"4","key":"5536_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1189\/jlb.1202624","volume":"74","author":"A David","year":"2003","unstructured":"David A, Kacher Y, Specks U, Aviram I (2003) Interaction of proteinase 3 with CD11b\/CD18 (beta2 integrin) on the cell membrane of human neutrophils. J Leukoc Biol 74(4):551\u2013557","journal-title":"J Leukoc Biol"},{"issue":"2","key":"5536_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4274\/balkanmedj.galenos.2018.2018.0852","volume":"36","author":"M Savran Karadeniz","year":"2019","unstructured":"Savran Karadeniz M, Alp Eni\u015fte I, \u015eent\u00fcrk \u00c7ift\u00e7i H, Usta S, Tefik T, \u015eanl\u0131 \u00d6 et al (2019) Neutrophil gelatinase-associated lipocalin significantly correlates with ischemic damage in patients undergoing laparoscopic partial nephrectomy. Balkan Med J 36(2):121\u2013128","journal-title":"Balkan Med J"},{"issue":"1\u20132","key":"5536_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0167-4838(00)00163-1","volume":"1482","author":"S Xu","year":"2000","unstructured":"Xu S, Venge P (2000) Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482(1\u20132):298\u2013307","journal-title":"Biochim Biophys Acta"},{"key":"5536_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/5584_2017_107","volume":"1047","author":"G Krzemie\u0144","year":"2018","unstructured":"Krzemie\u0144 G, Pa\u0144czyk-Tomaszewska M, Adamczuk D, Kotu\u0142a I, Demkow U, Szmigielska A (2018) Neutrophil gelatinase-associated lipocalin: a biomarker for early diagnosis of urinary tract infections in infants. Adv Exp Med Biol 1047:71\u201380","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"5536_CR23","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/ijc.22352","volume":"120","author":"R Lim","year":"2007","unstructured":"Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW et al (2007) Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 120(11):2426\u20132434","journal-title":"Int J Cancer"},{"issue":"21","key":"5536_CR24","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3748\/wjg.v12.i21.3344","volume":"12","author":"H Laurell","year":"2006","unstructured":"Laurell H, Bouisson M, Berthelemy P, Rochaix P, Dejean S, Besse P et al (2006) Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 12(21):3344\u20133351","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5536_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/10428194.2010.531413","volume":"52","author":"A Allegra","year":"2011","unstructured":"Allegra A, Alonci A, Bellomo G, Campo S, Cannav\u00f2 A, Penna G et al (2011) Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. Leuk Lymphoma 52(1):101\u2013107","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5536_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1160\/TH14-08-0690","volume":"113","author":"T Gremmel","year":"2015","unstructured":"Gremmel T, Koppensteiner R, Kaider A, Eichelberger B, Mannhalter C, Panzer S (2015) Impact of variables of the P-selectin - P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease. Thromb Haemost 113(4):806\u2013812","journal-title":"Thromb Haemost"},{"issue":"8","key":"5536_CR27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.5858\/2006-130-1144-ET","volume":"130","author":"S Sanchez","year":"2006","unstructured":"Sanchez S, Ewton A (2006) Essential thrombocythemia: a review of diagnostic and pathologic features. Arch Pathol Lab Med 130(8):1144\u20131150","journal-title":"Arch Pathol Lab Med"},{"key":"5536_CR28","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.363","author":"AM Vannucchi","year":"2007","unstructured":"Vannucchi AM, Barbui T (2007) Thrombocytosis and thrombosis. Hematol Am Soc Hematol Educ Program. https:\/\/doi.org\/10.1182\/asheducation-2007.1.363","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"5536_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","volume":"33","author":"A Falanga","year":"2005","unstructured":"Falanga A, Marchetti M, Vignoli A, Balducci D, Barbui T (2005) Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol 33(5):523\u2013530","journal-title":"Exp Hematol"},{"issue":"13","key":"5536_CR30","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","volume":"96","author":"A Falanga","year":"2000","unstructured":"Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M et al (2000) Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 96(13):4261\u20134266","journal-title":"Blood"},{"issue":"6","key":"5536_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-2006-949664","volume":"32","author":"JJ Michiels","year":"2006","unstructured":"Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH (2006) The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 32(6):589\u2013604","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"5536_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/MBC.0b013e32832f6c5b","volume":"20","author":"J Treli\u0144ski","year":"2009","unstructured":"Treli\u0144ski J, Tybura M, Smolewski P, Robak T, Chojnowski K (2009) The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia. Blood Coagul Fibrinolysis 20(8):646\u2013651","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"5536_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1600-0609.2010.01548.x","volume":"86","author":"K Abdulkarim","year":"2011","unstructured":"Abdulkarim K, Ridell B, Johansson P, Kutti J, Safai-Kutti S, Andr\u00e9asson B (2011) The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. Eur J Haematol 86(2):148\u2013155","journal-title":"Eur J Haematol"},{"issue":"1","key":"5536_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-019-02132-9","volume":"22","author":"M Maleknia","year":"2020","unstructured":"Maleknia M, Valizadeh A, Pezeshki SMS, Saki N (2020) Immunomodulation in leukemia: cellular aspects of anti-leukemic properties. Clin Transl Oncol 22(1):1\u201310","journal-title":"Clin Transl Oncol"},{"issue":"14","key":"5536_CR35","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1080\/10428194.2019.1630622","volume":"60","author":"S Shahrabi","year":"2019","unstructured":"Shahrabi S, Maleknia M, Tavakolifar Y, Zayeri DZ, Saki N (2019) Neutropenia and leukemia development: genetic risk factors and prognosis. Leuk Lymphoma 60(14):3363\u20133374","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5536_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ajh.21974","volume":"86","author":"M Panova-Noeva","year":"2011","unstructured":"Panova-Noeva M, Marchetti M, Spronk HM, Russo L, Diani E, Finazzi G et al (2011) Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera. Am J Hematol 86(4):337\u2013342","journal-title":"Am J Hematol"},{"key":"5536_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00240-0","author":"M Maleknia","year":"2020","unstructured":"Maleknia M, Ansari N, Haybar H, Maniati M, Saki N (2020) Inflammatory growth factors and in-stent restenosis: effect of cytokines and growth factors SN comprehensive. Clin Med. https:\/\/doi.org\/10.1007\/s42399-020-00240-0","journal-title":"Clin Med"},{"issue":"5","key":"5536_CR38","first-page":"940","volume":"90","author":"CE Ahnadi","year":"2003","unstructured":"Ahnadi CE, Sabrinah Chapman E, L\u00e9pine M, Okrongly D, Pujol-Moix N, Hern\u00e1ndez A et al (2003) Assessment of platelet activation in several different anticoagulants by the Advia 120 hematology system, fluorescence flow cytometry, and electron microscopy. Thromb Haemost 90(5):940\u2013948","journal-title":"Thromb Haemost"},{"issue":"1","key":"5536_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000314964","volume":"37","author":"M Milovanovic","year":"2010","unstructured":"Milovanovic M, Lotfi K, Lindahl T, Hallert C, J\u00e4remo P (2010) Platelet density distribution in essential thrombocythemia. Pathophysiol Haemost Thromb 37(1):35\u201342","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"5","key":"5536_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.exphem.2007.01.053","volume":"35","author":"A Falanga","year":"2007","unstructured":"Falanga A, Marchetti M, Vignoli A, Balducci D, Russo L, Guerini V et al (2007) V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules. Exp Hematol 35(5):702\u2013711","journal-title":"Exp Hematol"},{"issue":"2","key":"5536_CR41","first-page":"186","volume":"88","author":"JW Heemskerk","year":"2002","unstructured":"Heemskerk JW, Bevers EM, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88(2):186\u2013193","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"5536_CR42","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S0049-3848(08)70020-3","volume":"122","author":"FD George","year":"2008","unstructured":"George FD (2008) Microparticles in vascular diseases. Thromb Res 122(Suppl 1):S55\u2013S59","journal-title":"Thromb Res"},{"issue":"1","key":"5536_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.thromres.2013.05.003","volume":"132","author":"M Panova-Noeva","year":"2013","unstructured":"Panova-Noeva M, Marchetti M, Russo L, Tartari CJ, Leuzzi A, Finazzi G et al (2013) ADP-induced platelet aggregation and thrombin generation are increased in essential thrombocythemia and polycythemia vera. Thromb Res 132(1):88\u201393","journal-title":"Thromb Res"},{"issue":"1","key":"5536_CR44","first-page":"56","volume":"22","author":"S Kim","year":"2011","unstructured":"Kim S, Kunapuli SP (2011) P2Y12 receptor in platelet activation. Platelets 22(1):56\u201360","journal-title":"Platelets"},{"issue":"2","key":"5536_CR45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood-2003-05-1385","volume":"103","author":"C Leon","year":"2004","unstructured":"Leon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A et al (2004) Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103(2):594\u2013600","journal-title":"Blood"},{"issue":"21","key":"5536_CR46","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1182\/blood-2008-09-180794","volume":"113","author":"N Maugeri","year":"2009","unstructured":"Maugeri N, Rovere-Querini P, Evangelista V, Covino C, Capobianco A, Bertilaccio MT et al (2009) Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 113(21):5254\u20135265","journal-title":"Blood"},{"issue":"12","key":"5536_CR47","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2011-02-337337","volume":"118","author":"N Maugeri","year":"2011","unstructured":"Maugeri N, Malato S, Femia EA, Pugliano M, Campana L, Lunghi F et al (2011) Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. Blood 118(12):3359\u20133366","journal-title":"Blood"},{"issue":"7","key":"5536_CR48","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1182\/blood.V99.7.2612","volume":"99","author":"JF Viallard","year":"2002","unstructured":"Viallard JF, Solanilla A, Gauthier B, Contin C, D\u00e9chanet J, Grosset C et al (2002) Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 99(7):2612\u20132614","journal-title":"Blood"},{"issue":"1","key":"5536_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.transci.2011.11.013","volume":"46","author":"F Bilgir","year":"2012","unstructured":"Bilgir F, Bilgir O, Kebapcilar L, Calan M, Ozdemirkiran F, Cinali T et al (2012) Soluble CD40 ligand, high sensitive C-reactive protein and fetuin-A levels in patients with essential thrombocythemia. Transfus Apher Sci 46(1):67\u201371","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"5536_CR50","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1007\/s12032-012-0202-3","volume":"29","author":"J Treli\u0144ski","year":"2012","unstructured":"Treli\u0144ski J, Chojnowski K, Cebula-Obrzut B, Smolewski P (2012) Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: correlation with JAK2V617F mutational status and cytoreductive therapy. Med Oncol 29(4):2388\u20132395","journal-title":"Med Oncol"},{"issue":"6","key":"5536_CR51","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3109\/09537104.2012.731112","volume":"24","author":"G Rem\u00e9nyi","year":"2013","unstructured":"Rem\u00e9nyi G, Sz\u00e1sz R, Debreceni IB, Szarvas M, Bat\u00e1r P, Nagy B Jr et al (2013) Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets 24(6):486\u2013492","journal-title":"Platelets"},{"issue":"7","key":"5536_CR52","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3324\/haematol.13774","volume":"94","author":"MC Trappenburg","year":"2009","unstructured":"Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, ten Cate H, Leyte A et al (2009) Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 94(7):911\u2013918","journal-title":"Haematologica"},{"issue":"3","key":"5536_CR53","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","volume":"5","author":"ME Tesselaar","year":"2007","unstructured":"Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5(3):520\u2013527","journal-title":"J Thromb Haemost"},{"issue":"6","key":"5536_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1160\/TH02-09-0083","volume":"90","author":"V Rold\u00e1n","year":"2003","unstructured":"Rold\u00e1n V, Mar\u00edn F, Lip GY, Blann AD (2003) Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost 90(6):1007\u20131020","journal-title":"Thromb Haemost"},{"issue":"3","key":"5536_CR55","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1053\/j.seminoncol.2014.04.010","volume":"41","author":"S Mezouar","year":"2014","unstructured":"Mezouar S, Mege D, Darbousset R, Farge D, Debourdeau P, Dignat-George F et al (2014) Involvement of platelet-derived microparticles in tumor progression and thrombosis. Semin Oncol 41(3):346\u2013358","journal-title":"Semin Oncol"},{"issue":"1","key":"5536_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1160\/TH05-05-0310","volume":"95","author":"J Pereira","year":"2006","unstructured":"Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L et al (2006) Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 95(1):94\u201399","journal-title":"Thromb Haemost"},{"issue":"2","key":"5536_CR57","first-page":"362","volume":"100","author":"HM Spronk","year":"2008","unstructured":"Spronk HM, Dielis AW, De Smedt E, van Oerle R, Fens D, Prins MH et al (2008) Assessment of thrombin generation II: validation of the calibrated automated thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost 100(2):362\u2013364","journal-title":"Thromb Haemost"},{"issue":"8","key":"5536_CR58","doi-asserted-by":"publisher","first-page":"e43916","DOI":"10.1371\/journal.pone.0043916","volume":"7","author":"SP Tull","year":"2012","unstructured":"Tull SP, Bevins A, Kuravi SJ, Satchell SC, Al-Ani B, Young SP et al (2012) PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells. PLoS ONE 7(8):e43916","journal-title":"PLoS ONE"},{"issue":"10024","key":"5536_CR59","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0140-6736(14)62293-5","volume":"387","author":"MJ van Rooy","year":"2016","unstructured":"van Rooy MJ, Pretorius E (2016) Platelet interaction with erythrocytes and propensity to aggregation in essential thrombocythaemia. Lancet 387(10024):1210","journal-title":"Lancet"},{"issue":"11","key":"5536_CR60","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1182\/blood.V99.11.3978","volume":"99","author":"J Vall\u00e9s","year":"2002","unstructured":"Vall\u00e9s J, Santos MT, Aznar J, Mart\u00ednez M, Moscard\u00f3 A, Pi\u00f1\u00f3n M et al (2002) Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood 99(11):3978\u20133984","journal-title":"Blood"},{"issue":"6","key":"5536_CR61","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ajh.22024","volume":"86","author":"V De Stefano","year":"2011","unstructured":"De Stefano V, Rossi E, Za T, Ciminello A, Betti S, Luzzi C et al (2011) JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis. Am J Hematol 86(6):526\u2013528","journal-title":"Am J Hematol"},{"issue":"23","key":"5536_CR62","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1182\/blood-2013-06-501452","volume":"122","author":"CM Hobbs","year":"2013","unstructured":"Hobbs CM, Manning H, Bennett C, Vasquez L, Severin S, Brain L et al (2013) JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. Blood 122(23):3787\u20133797","journal-title":"Blood"},{"issue":"12","key":"5536_CR63","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.molmed.2005.10.003","volume":"11","author":"C James","year":"2005","unstructured":"James C, Ugo V, Casadevall N, Constantinescu SN, Vainchenker W (2005) A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. Trends Mol Med 11(12):546\u2013554","journal-title":"Trends Mol Med"},{"issue":"1","key":"5536_CR64","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12185-013-1475-9","volume":"99","author":"M Coucelo","year":"2014","unstructured":"Coucelo M, Caetano G, Sevivas T, Almeida Santos S, Fidalgo T, Bento C et al (2014) JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients. Int J Hematol 99(1):32\u201340","journal-title":"Int J Hematol"},{"issue":"5","key":"5536_CR65","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/bjh.13539","volume":"172","author":"JM Torregrosa","year":"2016","unstructured":"Torregrosa JM, Ferrer-Mar\u00edn F, Lozano ML, Moreno MJ, Martinez C, Anton AI et al (2016) Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation. Br J Haematol 172(5):813\u2013815","journal-title":"Br J Haematol"},{"issue":"3","key":"5536_CR66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1182\/blood-2008-01-135897","volume":"112","author":"AM Vannucchi","year":"2008","unstructured":"Vannucchi AM, Antonioli E, Guglielmelli P, Pancrazzi A, Guerini V, Barosi G et al (2008) Characteristics and clinical correlates of MPL 515W%3eL\/K mutation in essential thrombocythemia. Blood 112(3):844\u2013847","journal-title":"Blood"},{"issue":"4","key":"5536_CR67","first-page":"1137","volume":"26","author":"MK Ju","year":"2018","unstructured":"Ju MK, Fu RF, Li HY, Liu XF, Xue F, Chen YF et al (2018) Clinical Characteristic of \"triple-negative\" essential thrombocythaemia patients and mutation analysis by targeted Sequencing. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(4):1137\u20131145","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"4","key":"5536_CR68","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/1076029609332110","volume":"16","author":"KM Musallam","year":"2010","unstructured":"Musallam KM, Aoun EG, Mahfouz RA, Khalife M, Taher AT (2010) JAK2V617F and prothrombin G20210A gene mutations in a patient with Budd-Chiari syndrome and essential thrombocythemia. Clin Appl Thromb Hemost 16(4):472\u2013474","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"5536_CR69","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep.510310307","volume":"31","author":"MH Denninger","year":"2000","unstructured":"Denninger MH, Cha\u00eft Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A et al (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31(3):587\u2013591","journal-title":"Hepatology"},{"issue":"2","key":"5536_CR70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5505\/tjh.2012.03780","volume":"29","author":"O Mehtap","year":"2012","unstructured":"Mehtap O, Ate\u015fo\u011flu EB, Tarkun P, G\u00f6n\u00fcll\u00fc E, Keski H, Top\u00e7u Y et al (2012) The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera. Turk J Haematol 29(2):162\u2013169","journal-title":"Turk J Haematol"},{"issue":"12","key":"5536_CR71","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1161\/01.STR.0000098004.26252.EB","volume":"34","author":"T Hoekstra","year":"2003","unstructured":"Hoekstra T, Geleijnse JM, Kluft C, Giltay EJ, Kok FJ, Schouten EG (2003) 4G\/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 34(12):2822\u20132828","journal-title":"Stroke"},{"issue":"7","key":"5536_CR72","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/aje\/kwg024","volume":"157","author":"K Robien","year":"2003","unstructured":"Robien K, Ulrich CM (2003) 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157(7):571\u2013582","journal-title":"Am J Epidemiol"},{"issue":"2","key":"5536_CR73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ejh.12307","volume":"93","author":"V Buxhofer-Ausch","year":"2014","unstructured":"Buxhofer-Ausch V, Olcaydu D, Gisslinger B, Schalling M, Frantal S, Thiele J et al (2014) Decanucleotide insertion polymorphism of F7 significantly influences the risk of thrombosis in patients with essential thrombocythemia. Eur J Haematol 93(2):103\u2013111","journal-title":"Eur J Haematol"},{"issue":"3","key":"5536_CR74","doi-asserted-by":"publisher","first-page":"e34217","DOI":"10.1371\/journal.pone.0034217","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Lynch AI, Davis BR, Ford CE, Boerwinkle E, Eckfeldt JH et al (2012) Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study. PLoS ONE 7(3):e34217","journal-title":"PLoS ONE"},{"key":"5536_CR75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2350-12-107","volume":"12","author":"X Mo","year":"2011","unstructured":"Mo X, Hao Y, Yang X, Chen S, Lu X, Gu D (2011) Association between polymorphisms in the coagulation factor VII gene and coronary heart disease risk in different ethnicities: a meta-analysis. BMC Med Genet 12:107","journal-title":"BMC Med Genet"},{"issue":"11","key":"5536_CR76","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1056\/NEJM200009143431104","volume":"343","author":"D Girelli","year":"2000","unstructured":"Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S et al (2000) Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 343(11):774\u2013780","journal-title":"N Engl J Med"},{"issue":"1","key":"5536_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ajh.20399","volume":"80","author":"RR Cacciola","year":"2005","unstructured":"Cacciola RR, Cipolla A, Di Francesco E, Giustolisi R, Cacciola E (2005) Treatment of symptomatic patients with essential thrombocythemia: effectiveness of anagrelide. Am J Hematol 80(1):81\u201383","journal-title":"Am J Hematol"},{"issue":"7","key":"5536_CR78","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1076029615576741","volume":"22","author":"A Szumowska","year":"2016","unstructured":"Szumowska A, Galar M, Bolkun L, Kloczko J (2016) Plasma concentrations of protein Z and protein Z-dependent protease inhibitor in patients with essential thrombocythemia. Clin Appl Thromb Hemost 22(7):679\u2013684","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"5536_CR79","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/s-0037-1615649","volume":"85","author":"A Tabatabai","year":"2001","unstructured":"Tabatabai A, Fiehler R, Broze GJ Jr (2001) Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 85(4):655\u2013660","journal-title":"Thromb Haemost"},{"issue":"11","key":"5536_CR80","doi-asserted-by":"publisher","first-page":"e26762","DOI":"10.1371\/journal.pone.0026762","volume":"6","author":"H Brogren","year":"2011","unstructured":"Brogren H, Wallmark K, Deinum J, Karlsson L, Jern S (2011) Platelets retain high levels of active plasminogen activator inhibitor 1. PLoS ONE 6(11):e26762","journal-title":"PLoS ONE"},{"issue":"2","key":"5536_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0369-8114(00)00026-2","volume":"49","author":"J Briere","year":"2001","unstructured":"Briere J, Guilmin F (2001) Management of patients with essential thrombocythemia: current concepts and perspectives. Pathol Biol (Paris) 49(2):178\u2013183","journal-title":"Pathol Biol (Paris)"},{"issue":"1","key":"5536_CR82","first-page":"32","volume":"112","author":"A Undas","year":"2014","unstructured":"Undas A (2014) Fibrin clot properties and their modulation in thrombotic disorders. Thromb Haemost 112(1):32\u201342","journal-title":"Thromb Haemost"},{"issue":"1","key":"5536_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ajh.25303","volume":"94","author":"A Tefferi","year":"2019","unstructured":"Tefferi A, Barbui T (2019) Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 94(1):133\u2013143","journal-title":"Am J Hematol"},{"issue":"4","key":"5536_CR84","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ejh.12256","volume":"92","author":"O Moulard","year":"2014","unstructured":"Moulard O, Mehta J, Fryzek J, Olivares R, Iqbal U, Mesa RA (2014) Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol 92(4):289\u2013297","journal-title":"Eur J Haematol"},{"issue":"4","key":"5536_CR85","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1055\/s-2007-976165","volume":"33","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Elliott M (2007) Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Hemost 33(4):313\u2013320","journal-title":"Semin Thromb Hemost"},{"issue":"16","key":"5536_CR86","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1182\/blood-2014-08-596676","volume":"124","author":"G Finazzi","year":"2014","unstructured":"Finazzi G, Carobbio A, Guglielmelli P, Cavalloni C, Salmoiraghi S, Vannucchi AM et al (2014) Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia. Blood 124(16):2611\u20132612","journal-title":"Blood"},{"issue":"6","key":"5536_CR87","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Barosi G, Birgegard G, Cervantes F, Finazzi G, Griesshammer M et al (2011) Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol 29(6):761\u2013770","journal-title":"J Clin Oncol"},{"issue":"26","key":"5536_CR88","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","volume":"120","author":"T Barbui","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E et al (2012) Development and validation of an international prognostic score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood 120(26):5128\u20135133 quiz 252","journal-title":"Blood"},{"issue":"4","key":"5536_CR89","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ajh.24293","volume":"91","author":"M Haider","year":"2016","unstructured":"Haider M, Gangat N, Lasho T, Abou Hussein AK, Elala YC, Hanson C et al (2016) Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 mayo clinic patients. Am J Hematol 91(4):390\u2013394","journal-title":"Am J Hematol"},{"issue":"4","key":"5536_CR90","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ejh.13136","volume":"101","author":"Y Hashimoto","year":"2018","unstructured":"Hashimoto Y, Nakamae H, Tanaka T, Omura H, Horiuchi M, Yoshimura T et al (2018) Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia. Eur J Haematol 101(4):508\u2013513","journal-title":"Eur J Haematol"},{"issue":"1","key":"5536_CR91","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ajh.24607","volume":"92","author":"A Tefferi","year":"2017","unstructured":"Tefferi A, Barbui T (2017) Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 92(1):94\u2013108","journal-title":"Am J Hematol"},{"issue":"15","key":"5536_CR92","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","volume":"379","author":"J Grinfeld","year":"2018","unstructured":"Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R et al (2018) Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med 379(15):1416\u20131430","journal-title":"N Engl J Med"},{"issue":"7","key":"5536_CR93","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","volume":"3","author":"Y Pikman","year":"2006","unstructured":"Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M et al (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3(7):e270","journal-title":"PLoS Med"},{"issue":"11","key":"5536_CR94","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3324\/haematol.2014.113944","volume":"99","author":"L Malcovati","year":"2014","unstructured":"Malcovati L, Rumi E, Cazzola M (2014) Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic\/myeloproliferative neoplasms. Haematologica 99(11):1650\u20131652","journal-title":"Haematologica"},{"issue":"2","key":"5536_CR95","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4065\/81.2.159","volume":"81","author":"AP Wolanskyj","year":"2006","unstructured":"Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A (2006) Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 81(2):159\u2013166","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"5536_CR96","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1182\/blood-2012-10-429134","volume":"121","author":"C Patrono","year":"2013","unstructured":"Patrono C, Rocca B, De Stefano V (2013) Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. Blood 121(10):1701\u20131711","journal-title":"Blood"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05536-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:50:00Z","timestamp":1722966600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05536-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5536"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05536-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}